Hematopoietic Stem Cell Transplantation in an International Cohort of Colony Stimulating Factor‐1 Receptor ( CSF1R) ‐Related Disorder
Movement Disorders · 2025-09 · 40 (9) · 1826-1835
DOI: 10.1002/mds.30282 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Movement Disorders, online erschienen am 11.07.2025. Verfasst von Hemmo A F Yska und 22 weiteren Autor:innen. Beteiligte Einrichtung: INSERM U 1127, CNRS UMR 7225, Sorbonne Universités, UPMC Univ Paris 06 UMR S 1127, Institut du Cerveau, ICM, Paris, France. Hauptthemen laut MEDLINE: Hematopoietic Stem Cell Transplantation, Receptors, Granulocyte-Macrophage Colony-Stimulating Factor. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Colony stimulating factor‐1 receptor (CSF1R)‐related disorder (CSF1R‐RD) is an autosomal dominant, rapidly progressive, demyelinating disease leading to death usually within a few years. Because of the central role of CSF1R in microglia functions, allogeneic hematopoietic stem cell transplantation (HSCT) has been suggested as a therapy for CSF1R‐RD.
Objectives
To report multicenter clinical (Expanded Disability Scoring Scale [EDSS]), neurocognitive), neuroimaging (Sundal score), and biological (neurofilament light chain [NfL]) outcomes after HSCT in CSF1R‐RD.
Methods
We report an international cohort of 17 adult patients (8 females/9 males, 43.3 ± 9.4 years) who were treated in seven transplant centers. Patients were evaluated for a median of 2.5 years post‐HSCT, including one patient with follow‐up of 8 years. We also report neurological outcomes of the first child transplanted to date with biallelic CSF1R variants.
Results
In the first 6 months post‐HSCT, 2 patients died from early complications of myeloablative transplantation, and clinical and radiological severity scores worsened in most surviving adult patients. At 12 months post‐HSCT, most patients completely stabilized or improved in certain clinical domains. Radiological scores fully stabilized or slightly improved in all but one of the patients. Plasma/serum NfL sharply decreased in most patients after transplantation. Notably, 7/8 adult patients who received a reduced‐intensity conditioning regimen displayed similar neurological outcomes as patients who underwent myeloablative transplantation.
Conclusions
After an initial clinical and radiological deterioration in the first 6 months post‐transplantation, HSCT can halt disease progression in patients with CSF1R‐RD, regardless of their presenting clinical symptoms. The possibility of reduced conditioning regimens in CSF1R‐RD opens the way to treat older patients. © 2025 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- INSERM U 1127, CNRS UMR 7225, Sorbonne Universités, UPMC Univ Paris 06 UMR S 1127, Institut du Cerveau, ICM, Paris, France.
- Amsterdam UMC, Location AMC, Department of Child Neurology, Amsterdam Leukodystrophy Center, Emma Children's Hospital, Amsterdam, The Netherlands.
- Laboratoire d'Imagerie BiomédicaleSorbonne Université, INSERM, CNRS, Paris, France.
- Department of Neuroradiology, AP-HP, Pitié-Salpêtrière University Hospital, Paris, France.
- Cellular & Molecular Mechanisms, Amsterdam Neuroscience, Amsterdam, The Netherlands.
- Department of Neurology and Hertie-Institute for Clinical Brain Research, German Center of Neurodegenerative Diseases (DZNE), Tübingen, Germany.
ORCID-Profile: Anderson Rodrigues Brandao de Paiva, Fanny Mochel
Zitieren
APA
Yska, H. A. F., Golse, M., Beerepoot, S., Hayer, S., Bergner, C., de Paiva, A. R. B., Marelli, C., Palacios, N. J., Osorio, Y. L., Huiban, C., Franke, G., Wortmann, F., Holtick, U., Ayrignac, X., van der Knaap, M. S., Schöls, L., Perlbarg, V., Galanaud, D., de Witte, M. A., …, & and the International CSF1R‐RD Working Group (2025). Hematopoietic Stem Cell Transplantation in an International Cohort of Colony Stimulating Factor‐1 Receptor ( CSF1R) ‐Related Disorder. Movement Disorders, 40(9), 1826-1835. https://doi.org/10.1002/mds.30282
Vancouver
Yska HAF, Golse M, Beerepoot S, Hayer S, Bergner C, de Paiva ARB, et al. Hematopoietic Stem Cell Transplantation in an International Cohort of Colony Stimulating Factor‐1 Receptor ( CSF1R) ‐Related Disorder. Movement Disorders. 2025;40(9):1826-1835. doi:10.1002/mds.30282
BibTeX
@article{Yska2025,
author = {Yska, Hemmo A F and Golse, Marianne and Beerepoot, Shanice and Hayer, Stefanie and Bergner, Caroline and de Paiva, Anderson Rodrigues Brandao and Marelli, Cecilia and Palacios, Natalia Julia and Osorio, Yudy Llamas and Huiban, Camille and Franke, Georg and Wortmann, Friederike and Holtick, Udo and Ayrignac, Xavier and van der Knaap, Marjo S and Schöls, Ludger and Perlbarg, Vincent and Galanaud, Damien and de Witte, Moniek A and Wolf, Nicole I and Nguyen, Stéphanie and Mochel, Fanny and and the International CSF1R‐RD Working Group, and the International CSF1R‐RD Working Group},
title = {Hematopoietic Stem Cell Transplantation in an International Cohort of Colony Stimulating Factor‐1 Receptor ( CSF1R) ‐Related Disorder},
journal = {Movement Disorders},
year = {2025},
volume = {40},
number = {9},
pages = {1826--1835},
doi = {10.1002/mds.30282}
}
EUVIMED